Medicilon in one place
Dive Deeper
Corporate News
- Corporate News
Breaking New Ground in Alzheimer’s Disease! Medicilon Supports Hengrui Pharma’s SHR-3201 Injection to Secure Clinical Trial Approval
- Corporate News
Breaking the “King of Cancer”: First-in-Class ADC MC001. Medicilon Supports Partner Medicovestor to Secure FDA IND Clearance
- Corporate News
Medicilon’s Dr. Chunlin Chen Engages FDA Experts at SAPA-DC Annual Conference to Discuss Global IND Development and NAMs Technologies for Innovative Medicines
- Corporate News
Medicilon TPD (PROTAC, Molecular Glue) Service Platform
- Corporate News
Medicilon’s Antibody-Peptide Conjugates Service Platform
- Corporate News
ACEA Pharma’s Ogrelvir Sodium Capsule Named in Nature’s 2025 Top Novel Target Drugs List with R&D Support from Medicilon
Events
- Events
Oct. 15 (Thu.) - 16 (Fri.), 2026. Venue, Alpensia Resort, Pyeongchang, South Korea.
50th Korean Society of Nonclinical Studies (KSNS)
- Events
Oct. 7 (Wed.) - 9 (Fri.), 2026 10:00-17:00. Venue, PACIFICO Yokohama.
BIOJAPAN 2026
- Events
Basel, Switzerland from September 6-10, 2026
EFMC-ISMC 2026
- Events
Date: August 27-28, 2026
Venue:The Westin Seoul Parnas, South Korea - Medicilon Booth #6
Venue:The Westin Seoul Parnas, South Korea - Medicilon Booth #6
4th SMC and AimedBio ADC Conference
- Events
Date: August 23-27, 2026
Venue: McCormick Place Convention Center, Chicago, IL - Medicilon Booth #400
Venue: McCormick Place Convention Center, Chicago, IL - Medicilon Booth #400
ACS Fall 2026
- Events
Date: September 10, 2026 (Thursday)
Venue: EL Tower, Ruby Hall, Yangjae, Seoul
Venue: EL Tower, Ruby Hall, Yangjae, Seoul
【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026
Medicilon Academy
- Medicilon Academy
【Case Study】New Approach Methods NAMs
- Medicilon Academy
【Case Study】Route, Solid-State, and Impurity Optimization (Small-Molecule API)
- Medicilon Academy
【Case Study】IND Completion in 12 Months (Small-Molecule NCE)
- Medicilon Academy
Boston Non-Tumor Models Innovation
- Medicilon Academy
【White Paper】Navigating the DMPK Gauntlet: A Strategic Analysis of the Interconnected Challenges Shaping the Future of Drug Development
- Medicilon Academy
【White Paper】Patient-Derived Xenograft Organoids: Advancements and Applications in Precision Oncology
Digital Materials
- Digital Materials
NAMs: MODEL-INFORMED DRUG DEVELOPMENT BASED PREDICTION BY INTEGRATING AI-ADMET WITH PBPK
- Digital Materials
A Sensitive LC–MS Bioanalytical Method for Simultaneous Quantification of Structurally Similar Cyclic Tetrapeptides at the Picogram Level (Download)
- Digital Materials
Quantification of antibody-Conjugated Drug in Cleavable ADCs: A Universal, Automated, and Cost-Effective LC-MS/MS Platform (Download)
- Digital Materials
Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)
- Digital Materials
Integrated Mass Spectrometric Workflows Enabling Next-Generation Conjugate Therapeutics in Cancer Research (Download)
- Digital Materials
